RANCHO CORDOVA, Calif., April 10, 2019 /PRNewswire/ -- ThermoGenesis Corp., a wholly owned subsidiary of Cesca Therapeutics(Nasdaq: KOOL), and a market leader in automated cellular processing and autologous cell therapies for regenerative medicine, today announced that its AXP® II System for cord blood processing and PXP® System for point-of-care harvesting of highly enriched
"Expanding our footprint into Southeast Asia is a logical next step, especially as research and development activities in the field of cell therapy are robust across Asia," said Haihong Zhu, ThermoGenesis' President. "We look forward to supporting the needs of hospitals, clinics and GMP laboratory customers with our state-of-the-art and cost-effective cell-based therapy tools."
About the AXP® II SystemThe AXP® II System is a proprietary, automated system for the isolation, collection and storage of hematopoietic stem cell concentrates from cord blood.Its functionality:
The AXP® II System includes the AXP II Device, AXP II Docking Station, AXP Processing Bag Set, XpressTRAK® software and accessories.
About the PXP® System The PXP® laboratory equipment allows for the rapid, automated processing of autologous bone marrow-derived stem cells at the point of care, such as in surgical centers and clinics. It affords:
About ThermoGenesisThermoGenesis develops, commercializes and markets a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology. The Company has developed an automated, functionally-closed CAR-TXpress™ platform to streamline the manufacturing process for the emerging CAR-T immunotherapy market. For additional information, please visit: www.thermogenesis.com.
About Cesca Therapeutics Inc.Cesca Therapeutics Inc. is a market leader in cell processing technologies and autologous cell therapies for regenerative medicine. For more information, visit: www.cescatherapeutics.com.
Company Contact: Wendy Samford916firstname.lastname@example.org
Investor Contact: Paula Schwartz, Rx Communications917email@example.com
View original content:http://www.prnewswire.com/news-releases/thermogenesis-axp-ii-and-pxp-systems-now-registered-and-available-in-thailand-300829515.html
SOURCE Cesca Therapeutics Inc.
Subscribe to our Free Newsletters!